AT13387
Showing 1 - 15 of 15
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in United States (CDK Inhibitor
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- CDK Inhibitor AT7519
- +3 more
-
Washington, District of Columbia
- +5 more
Oct 18, 2022
BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Malignant Solid Tumor Trial in Boston (Dabrafenib,
Active, not recruiting
- BRAF V600E Mutation Present
- +9 more
- Dabrafenib
- +4 more
-
Boston, Massachusetts
- +1 more
Jun 28, 2022
Metastatic Solid Tumors Trial in Tucson, Boston (AT13387)
Completed
- Metastatic Solid Tumors
- AT13387
-
Tucson, Arizona
- +3 more
Jan 13, 2020
Gastrointestinal Stromal Tumor (GIST) Trial in United States (AT13387 and Imatinib)
Completed
- Gastrointestinal Stromal Tumor (GIST)
- AT13387 and Imatinib
-
Tucson, Arizona
- +7 more
Jan 13, 2020
Solid Tumors, Breast Cancer Trial run by the NCI (AT13387)
Completed
- Solid Tumors
- Breast Cancer
- AT13387
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 3, 2018
Persistent Asthma Trial in United States (Beclomethasone Dipropionate 640, Placebo, Beclomethasone dipropionate via 320 mcg BAI)
Completed
- Persistent Asthma
- Beclomethasone Dipropionate 640
- +4 more
-
Peoria, Arizona
- +74 more
Nov 5, 2021
Dental Implants, Transplants Trial in Damascus (Efficacy of free gingival grafts during in the increasing of peri-implant
Completed
- Dental Implants
- Transplants
- Efficacy of free gingival grafts during in the increasing of peri-implant keratinized tissue width and soft tissues thickness
- +2 more
-
Damascus, Syrian Arab RepublicDamascus University
Sep 27, 2023
TRU-IMMUNO: Optimizing Liver Immunosuppression
Not yet recruiting
- Liver Transplant Rejection
- Patients monitored with TruGraf and TRAC Liver testing
- (no location specified)
Apr 26, 2022
TruGraf® Long-term Clinical Outcomes Study
Recruiting
- Kidney Transplant Rejection
- Patients monitored with TruGraf and TRAC testing
-
Tucson, Arizona
- +35 more
Apr 26, 2022
NSCLC(NSCLC) Trial in Worldwide (AT13387, Crizotinib)
Completed
- Non-small Cell Lung Cancer(NSCLC)
- AT13387
- Crizotinib
-
Scottsdale, Arizona
- +64 more
Jan 17, 2018
Cell-free DNA as a Biomarker After Lung Transplantation
Completed
- Lung Transplant Rejection
- No Intervention
- (no location specified)
Feb 13, 2020
Adult Solid Tumor, Estrogen Receptor Negative, Fallopian Tube Serous Tumor Trial (Hsp90 Inhibitor AT13387, Laboratory Biomarker
Withdrawn
- Adult Solid Neoplasm
- +12 more
- Hsp90 Inhibitor AT13387
- +3 more
- (no location specified)
Jul 22, 2016
Prostate Cancer Trial in Worldwide (AT13387, abiraterone acetate, Prednisone)
Completed
- Prostate Cancer
- AT13387
- +2 more
-
Los Angeles, California
- +31 more
Sep 6, 2016
Acute Rejection After Organ Transplantation
Unknown status
- Organ Transplant Rejection
- no interventions
-
Fuzhou, Fujian, ChinaFuzhou General Hospital, Xiamen Univ Fuzhou, Fujian China
Aug 16, 2017
Cancer Trial in Bath, Bristol (Distress Thermometer and Problems List, Usual psychosocial support)
Completed
- Cancer
- Distress Thermometer and Problems List
- Usual psychosocial support
-
Bath, Somerset, United Kingdom
- +1 more
Apr 1, 2014